Your session is about to expire
← Back to Search
Behavioral Intervention
Effects of Online App Weight Loss Programs on Liver Health in Obese Adults
N/A
Waitlist Available
Research Sponsored by Noom Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to day 168
Awards & highlights
No Placebo-Only Group
Summary
This trial uses an app-based weight loss program to help obese adults lose weight and improve their liver health.
Eligible Conditions
- Weight Loss
- Non-alcoholic Fatty Liver Disease
- Obesity
- Nonalcoholic fatty liver disease
- Fatty Liver Disease
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline to day 168
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to day 168
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in BMI
Secondary study objectives
Change Weight Efficacy Life-Style (WEL) subscale scores (negative emotion, availability, social pressure, physical discomfort, and positive activities) and a global score
Change in RAND-36 domain scores (emotional well-being, energy/fatigue, general health, pain, physical functioning, role limitations due to emotional problems, role limitations due to physical health, and social functioning).
Fibroscan
+1 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Noom Healthy Weight ProgramExperimental Treatment1 Intervention
The Noom platform uses a cognitive behavioral approach to weight loss that integrates set content with interaction with live coaches to support client efforts at behavior change. The Healthy Weight program follows guidelines from the Obesity Society's "2013 Guidelines for the Management of Overweight and Obesity in Adults" NIH "Practical Guide on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults". It has 52 weeks of curriculum with 1-3 articles to read per day (Reading level: Grade 6-8).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Noom Healthy Weight Program
2021
N/A
~70
Find a Location
Who is running the clinical trial?
Arizona Liver HealthUNKNOWN
1 Previous Clinical Trials
22 Total Patients Enrolled
Noom Inc.Lead Sponsor
16 Previous Clinical Trials
2,801 Total Patients Enrolled
6 Trials studying Weight Loss
1,518 Patients Enrolled for Weight Loss
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are a woman who has been diagnosed with premenstrual syndrome or premenstrual dysphoric disorder.You are not planning to change your smoking habits during the study.You have a very strict or unusual diet, like the Atkins diet, high protein diet, or intermittent fasting. You also have an eating disorder.You cannot plan to quit or start smoking during the study.
Research Study Groups:
This trial has the following groups:- Group 1: Noom Healthy Weight Program
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.